Literature DB >> 490180

Lymphocyte function in myasthenia gravis.

S Kawanami, A Kanaide, Y Itoyama, Y Kuroiwa.   

Abstract

Mitogen-induced blastoid transformation of peripheral blood lymphocytes from patients with myasthenia gravis was studied using a microplate culture technique and evaluated with 3H-thymidine incorporation. It was found that both phytohaemagglutinin and pokeweed mitogen responses decreased significantly in patients with myasthenia gravis. In myasthenic crisis, indices of stimulation by phytohaemagglutination became very low. The autologous plasma neither inhibited nor facilitated mitogenic responses of lymphocytes. The decreased mitogen responsiveness of lymphocytes suggests that part of the T lymphocyte function is subnormal in myasthenia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 490180      PMCID: PMC490307          DOI: 10.1136/jnnp.42.8.734

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS.

Authors:  P KORNFELD; S SIEGAL; L B WEINER; K E OSSERMAN
Journal:  Ann Intern Med       Date:  1965-09       Impact factor: 25.391

2.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

3.  The effects of thymectomy on the lymphocyte count in patients with myasthenia gravis.

Authors:  R A JOSKE
Journal:  Med J Aust       Date:  1958-12-27       Impact factor: 7.738

4.  A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.

Authors:  V M Monnier; B W Fulpius
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

5.  Immunological function of the thymus.

Authors:  J F MILLER
Journal:  Lancet       Date:  1961-09-30       Impact factor: 79.321

6.  Inhibition of human lymphocyte stimulation by steroid hormones: cytokinetic mechanisms.

Authors:  J Mendelsohn; M M Multer; J L Bernheim
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

7.  Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.

Authors:  T Shirai; M Miyata; A Nakase; T Itoh
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

8.  Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).

Authors:  C Morimoto
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

9.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

10.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

View more
  3 in total

Review 1.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

Authors:  H J Sagar; G A Davies-Jones; I D Allonby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

3.  Immune disease and HLA associations with myasthenia gravis.

Authors:  P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.